Status:
COMPLETED
Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
Lead Sponsor:
Glaukos Corporation
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluation of intraocular pressure (IOP) lowering effect of one iStent versus two iStents in conjunction with cataract surgery in subjects with primary open-angle glaucoma, washed out of one anti-glau...
Eligibility Criteria
Inclusion
- Phakic study eye requiring cataract removal and posterior chamber intraocular lens (PC-IOL) implantation
- Primary open-angle glaucoma (including pigmentary or pseudoexfoliative)
Exclusion
- Aphakic or pseudophakic with posterior or anterior chamber IOLs (PC-IOLs or AC-IOLs) (study eye)
- Prior stent implantations (study eye)
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2019
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT01455467
Start Date
September 1 2011
End Date
October 18 2019
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayan Ophthalmological Center
Yerevan, Armenia, 0001